Choose Your News
Loading...
Thumbnail
The new standard means nearly half of American adults qualify for a diagnosis of high blood pressure. [Read More]
Thumbnail
Experts set new targets for treatment of hypertension on Monday, greatly expanding the number of adults who will qualify for the diagnosis. [Read More]
Thumbnail
New criteria is 1st official diagnostic revision since 2003... [Read More]
The new study, published in the Lancet, stunned leading cardiologists by countering decades of clinical experience. The findings raise questions about whether stents should be... [Read More]
Thumbnail
Physical activity made all the difference to participants who managed to keep the pounds from returning, a new study finds. [Read More]
Thumbnail
Physical activity made all the difference to participants who managed to keep the pounds from returning, a new study finds. [Read More]
Thumbnail
Open-access academic publications were supposed to lower the barriers to knowledge. But when the walls came down, opportunists came in. [Read More]
Thumbnail
The patients were children who had inherited a mutated gene causing a rare disorder, adrenoleukodystrophy, or ALD. [Read More]
Thumbnail
With a disabled AIDS virus, doctors supply a gene to boys with a degenerative neural condition. [Read More]
Yale researchers calculated that, if contact sports could be made noncontact, there would be 49,600 fewer injuries among male college athletes per year and 601,900... [Read More]
The college student, imprisoned for more than a year in North Korea, fell into a vegetative state after blood flow to his brain was cut... [Read More]
The first gene therapy treatment in the United States was approved recently by the Food and Drug Administration, heralding a new era in medicine that... [Read More]
Kymriah, approved recently by the F.D.A., with a $475,000 price tag, is first of a coming wave of treatments whose expected prices have alarmed economists,... [Read More]
The precise numbers offered by some testing services raise eyebrows among genetics researchers. "It's all privatized science, and the algorithms are not generally available for... [Read More]
Widespread DNA testing has shed light on the ancestry of millions of Americans. But these services have limitations, and the results can be uncertain. [Read More]
Widespread DNA testing has shed light on the ancestry of millions of Americans. But these services have limitations, and the results can be uncertain. [Read More]
With the arrival of two revolutionary treatment strategies, immunotherapy and personalized medicine, cancer researchers have found new hope — and a problem that is perhaps... [Read More]
Companies scrambling to test new drugs are fighting for limited supply of patients. [Read More]
There are too many experimental cancer drugs in too many clinical trials, and not enough patients to test them on. [Read More]
Breakthroughs in immunotherapy and a rush to develop profitable new treatments have brought a crush of clinical trials scrambling for patients. [Read More]
Loading...
Preview